Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Felce

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The British Journal of Psychiatry : the Journal of Mental Science|May 2, 2000
Reducing antipsychotic medication in people with a learning disabilityZ Ahmed, W Fraser, M P Kerr, et al.
Research in Developmental Disabilities|August 29, 2001
The adaptive behavior scale-residential and community (part I): towards the development of a short formC Hatton, E Emerson, J Robertson, et al.
Journal of Intellectual Disability Research : JIDR|October 2, 2002
Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approachC Smith, D Felce, Z Ahmed, et al.
Journal of Intellectual Disability Research : JIDR|January 11, 2014
Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource useD Felce, D Cohen, P Willner, et al.
Health Technology Assessment (Winchester, England)|May 25, 2013
A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilitiesP Willner, J Rose, A Jahoda, et al.
Molecular Cancer Therapeutics|November 26, 2009
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivoSean G Buchanan, Jorg Hendle, Patrick S Lee, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The British Journal of Psychiatry : the Journal of Mental Science|May 2, 2000
Reducing antipsychotic medication in people with a learning disabilityZ Ahmed, W Fraser, M P Kerr, et al.
Research in Developmental Disabilities|August 29, 2001
The adaptive behavior scale-residential and community (part I): towards the development of a short formC Hatton, E Emerson, J Robertson, et al.
Journal of Intellectual Disability Research : JIDR|October 2, 2002
Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approachC Smith, D Felce, Z Ahmed, et al.
Journal of Intellectual Disability Research : JIDR|January 11, 2014
Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource useD Felce, D Cohen, P Willner, et al.
Health Technology Assessment (Winchester, England)|May 25, 2013
A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilitiesP Willner, J Rose, A Jahoda, et al.
Molecular Cancer Therapeutics|November 26, 2009
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivoSean G Buchanan, Jorg Hendle, Patrick S Lee, et al.
Pageof 5